Physician profile
Leslie Gorrell
NPI 1669972527
$5,436.01
in general payments reported to CMS, 2019-2025
27 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,720 · 2022: $217 · 2023: $576 · 2024: $632 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,968 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,968.10 |
| Travel and Lodging | $530.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,638.26 | 2021-2023 | Bulkamid |
| Boston Scientific Corporation | $1,191.77 | 2021-2025 | Ams 700 Cxr Rte Kit, Ams 700, General - Erectile Dysfunction |
| Teleflex LLC | $891.20 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $254.92 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $250.30 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $197.49 | 2021-2024 | Aveed, Xiaflex |
| Abc Home Medical Supply, INC. | $160.15 | 2022-2024 | |
| Endo USA, INC. | $148.57 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $147.36 | 2022-2025 | Interstim |
| Blue Earth Diagnostics | $71.90 | 2022-2023 | |
| C. R. Bard, INC. & Subsidiaries | $56.98 | 2025 | Aptra |
| Baxter Healthcare | $49.50 | 2023 | Perclot, Floseal |
| Bluewind Medical | $41.16 | 2025 | |
| Abbvie INC. | $38.26 | 2022-2024 | |
| Tolmar, INC. | $34.32 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $29.41 | 2022 | |
| Coloplast Corp | $28.75 | 2023-2024 | Titan |
| Dendreon Pharmaceuticals LLC | $28.22 | 2024 | Provenge |
| Accord Healthcare, INC. | $24.45 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $24.25 | 2024 | Exparel, Iovera |
| Myriad Genetic Laboratories, INC. | $23.86 | 2024 | Prolaris |
| Civco Medical Instruments | $23.40 | 2024 | |
| 180 Medical, INC. | $22.05 | 2022 | |
| Profound Medical Corp. | $16.49 | 2025 | Tulsa-Pro |
| Astrazeneca Pharmaceuticals LP | $15.18 | 2024 | Lynparza |
| Olympus America INC. | $14.69 | 2024 | Itind System |
| Angiodynamics, INC. | $13.12 | 2023 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Gorrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.